2020
DOI: 10.1080/08039488.2020.1736151
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of deficit schizophrenia and reliability of the bidimensional model of its negative symptomatology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 59 publications
0
1
1
Order By: Relevance
“…We found that individuals with SCZ-D, but not those with SCZ-ND, show worse adherence to MD compared with healthy controls. The dosage of antipsychotics was significantly higher in subjects with SCZ-D, which is not in line with previous studies [27][28][29]. Despite of this fact, the correlation of the aMED score with CPZeq was not significant.…”
Section: Discussioncontrasting
confidence: 84%
“…We found that individuals with SCZ-D, but not those with SCZ-ND, show worse adherence to MD compared with healthy controls. The dosage of antipsychotics was significantly higher in subjects with SCZ-D, which is not in line with previous studies [27][28][29]. Despite of this fact, the correlation of the aMED score with CPZeq was not significant.…”
Section: Discussioncontrasting
confidence: 84%
“…It is predicted that patients with bipolar disorder II may show reduced pareidolia than patients with bipolar disorder I. However, subgroups of schizophrenia with varying degrees of negative symptoms [i.e., deficit vs. non-deficit schizophrenia, (78,79)] may not show any differences in measures of pareidolia. Further, future studies should also investigate pareidolia in individuals with schizotypal personality disorder as well as other patient groups with schizophrenia-related disorders, such as schizoaffective disorder.…”
Section: Limitations and Future Studiesmentioning
confidence: 99%